top of page
Earlier detection changes outcomes. Collaboration makes it possible.
Be part of advancing the future of breast cancer detection.
Start the conversation
Our work is driven through collaboration with clinical partners, research institutions, healthcare organisations and investors. Contact us to learn more or explore partnership opportunities. Enquiries are welcome via the form below or by contacting us directly.
Balanced Risk Profile // Faster Diagnostics remains a pre-revenue venture undergoing clinical validation. Regulatory approval and adoption timelines pose inherent uncertainty. However, the unmet need, early performance data, and strong UK policy environment provide an attractive risk-reward profile with potential for high impact.
bottom of page